120+ Patient Advocates Urge Congress to Reauthorize FDA User Fee Agreements

The current Food & Drug Administration (FDA) user fee agreements are the culmination of months of negotiation between FDA and the medical product industry, with significant input from the patient advocacy community. Patient advocates, representing the millions of men, women, and children in the United States living with chronic or rare diseases and disabilities, stand behind these agreements and ask that they are reauthorized as quickly as possible.

Show PDF Only: 
Friday, May 5, 2017 (All day)